Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


27.03.2017

1 Am J Cardiol
9 Am J Emerg Med
2 Ann Intern Med
5 Ann Thorac Surg
4 BMJ
58 Catheter Cardiovasc Interv
2 Circ Cardiovasc Qual Outcomes
2 Circ J
3 Circulation
1 Clin Cardiol
1 Clin Chem
2 Dtsch Med Wochenschr
2 Eur Heart J
1 Int J Cardiol
1 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
3 J Clin Endocrinol Metab
2 JAMA
3 Lancet
6 N Engl J Med
4 PLoS One
1 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. ROBERTS JK, Rao SV, Shaw LK, Gallup DS, et al
    Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Am J Cardiol. 2017 Feb 9. pii: S0002-9149(17)30128.
    PubMed     Text format     Abstract available


    Am J Emerg Med

  2. KUDO D, Kushimoto S, Shiraishi A, Ogura H, et al
    The impact of preinjury antithrombotic medication on hemostatic interventions in trauma patients.
    Am J Emerg Med. 2017;35:62-65.
    PubMed     Text format     Abstract available

  3. PARK JH, Kim YK, Kim B, Kim J, et al
    Diagnostic performance of smartphone reading of the coronary computed tomography angiography in patients with acute chest pain at ED.
    Am J Emerg Med. 2016 Jun 7. pii: S0735-6757(16)30220.
    PubMed     Text format     Abstract available

  4. NABLE JV, Lawner BJ, Brady WJ
    2016: emergency medical services annotated literature in review.
    Am J Emerg Med. 2016;34:2193-2199.
    PubMed     Text format     Abstract available

  5. MADSEN T, Smyres C, Wood T, Moores T, et al
    Cardiology consultation reduces provocative testing rates in an ED observation unit.
    Am J Emerg Med. 2017;35:25-28.
    PubMed     Text format     Abstract available

  6. WU WK, Yiadom MY, Collins SP, Self WH, et al
    Documentation of HEART score discordance between emergency physician and cardiologist evaluations of ED patients with chest pain.
    Am J Emerg Med. 2016 Sep 28. pii: S0735-6757(16)30659.
    PubMed     Text format     Abstract available

  7. YUN-TAO Z, Chen CC
    The role of electrocardiogram in diagnosis of acute pericarditis after Wellens syndrome.
    Am J Emerg Med. 2017;35:175-176.
    PubMed     Text format    

  8. RILEY RF, Miller CD, Russell GB, Harper EN, et al
    Cost analysis of the History, ECG, Age, Risk factors, and initial Troponin (HEART) Pathway randomized control trial.
    Am J Emerg Med. 2017;35:77-81.
    PubMed     Text format     Abstract available

  9. NESTLER DM, Gilani WI, Anderson RT, Bellolio MF, et al
    Does gender bias in cardiac stress testing still exist? A videographic analysis nested in a randomized controlled trial.
    Am J Emerg Med. 2017;35:29-35.
    PubMed     Text format     Abstract available

  10. DUBIN J, Kiechle E, Wilson M, Timbol C, et al
    Mean HEART scores for hospitalized chest pain patients are higher in more experienced providers.
    Am J Emerg Med. 2016 Oct 18. pii: S0735-6757(16)30733.
    PubMed     Text format     Abstract available


    Ann Intern Med

  11. BORGES FK, Devereaux PJ
    PCI with drug-eluting stents </= 12 months before surgery was linked to increased MI and cardiac death after surgery.
    Ann Intern Med. 2017;166:JC35.
    PubMed     Text format    

  12. MARTINEZ AM, Sanchez RC, Lacunza-Ruiz J, Ayala JM, et al
    Acute Myocardial Infarction Masked by Brugada Syndrome: A Case Report.
    Ann Intern Med. 2017;166:449-450.
    PubMed     Text format    


    Ann Thorac Surg

  13. CURTIS M, Deng Y, Lee VV, Elayda MA, et al
    Effect of Dose and Timing of Preoperative Statins on Mortality After Coronary Artery Bypass Surgery.
    Ann Thorac Surg. 2017 Mar 15. pii: S0003-4975(17)30016.
    PubMed     Text format     Abstract available

  14. AMIN S, Pinho-Gomes AC, Taggart DP
    Relationship of Intraoperative Transit Time Flowmetry Findings to Angiographic Graft Patency at Follow-Up.
    Ann Thorac Surg. 2016 Feb 12. pii: S0003-4975(15)01779.
    PubMed     Text format     Abstract available

  15. SATO M, Yamanaka H, Iwasaki M, Miyata Y, et al
    Altered Phosphatidylinositol 3-Kinase and Calcium Signaling in Cardiac Dysfunction After Brain Death in Rats.
    Ann Thorac Surg. 2016;102:556-63.
    PubMed     Text format     Abstract available

  16. HWANG HY, Lee KH, Han JW, Kim KB, et al
    Equivalency of Saphenous Vein and Arterial Composite Grafts: 5-Year Angiography and Midterm Clinical Follow-Up.
    Ann Thorac Surg. 2016 May 18. pii: S0003-4975(16)00193.
    PubMed     Text format     Abstract available

  17. ATHANASIOU T, Ashrafian H, Harling L, Casula RP, et al
    Bailouts to LIMA Damage for Avoiding Conversion in Minimal Access Coronary Procedures.
    Ann Thorac Surg. 2016;102:e173-6.
    PubMed     Text format     Abstract available


    BMJ

  18. MUKAMAL K, Lazo M
    Alcohol and cardiovascular disease.
    BMJ. 2017;356:j1340.
    PubMed     Text format    

  19. MAYOR S
    Evolocumab reduces cardiovascular events in patients with heart disease, finds study.
    BMJ. 2017;356:j1394.
    PubMed     Text format    

  20. BELL S, Daskalopoulou M, Rapsomaniki E, George J, et al
    Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records.
    BMJ. 2017;356:j909.
    PubMed     Text format     Abstract available

  21. WISE J
    NICE recommends ticagrelor with aspirin for three years post-MI.
    BMJ. 2016;354:i4438.
    PubMed     Text format    


    Catheter Cardiovasc Interv

  22. BADINGS EA, Remkes WS, The SH, Dambrink JE, et al
    Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.
    Catheter Cardiovasc Interv. 2016;88:755-764.
    PubMed     Text format     Abstract available

  23. RIZIK DG, Shah MG, Burke RF
    First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2016;88:899-901.
    PubMed     Text format     Abstract available

  24. ELGENDY IY, Kumbhani DJ, Mahmoud AN, Wen X, et al
    Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016;88:765-774.
    PubMed     Text format     Abstract available

  25. JAGUSZEWSKI M, Dorig M, Frangieh AH, Ghadri JR, et al
    Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2016;88:E173-E182.
    PubMed     Text format     Abstract available

  26. ELLWEIN L, Marks DS, Migrino RQ, Foley WD, et al
    Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design.
    Catheter Cardiovasc Interv. 2016;87:1244-55.
    PubMed     Text format     Abstract available

  27. TANAKA A, Jabbour RJ, Kawamoto H, Mangieri A, et al
    Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
    Catheter Cardiovasc Interv. 2016;88:865-870.
    PubMed     Text format     Abstract available

  28. TANAKA A, Latib A, Kawamoto H, Jabbour RJ, et al
    Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
    Catheter Cardiovasc Interv. 2016;88:854-862.
    PubMed     Text format     Abstract available

  29. BENNETT J, Adriaenssens T, Desmet W, Dubois C, et al
    Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and d
    Catheter Cardiovasc Interv. 2016;88:843-853.
    PubMed     Text format     Abstract available

  30. CHADHA DS, Sumana B, Karthikeyan G, Jayaprasad V, et al
    Prevalence of aspirin resistance in Asian-Indian patients with stable coronary artery disease.
    Catheter Cardiovasc Interv. 2016;88:E126-E131.
    PubMed     Text format     Abstract available

  31. SINGH S, Singh N, Gulati GS, Ramakrishnan S, et al
    Dual-Source Computed Tomography for Chronic Total Occlusion of Coronary Arteries.
    Catheter Cardiovasc Interv. 2016;88:E117-E125.
    PubMed     Text format     Abstract available

  32. SANCHEZ CE, Dota A, Badhwar V, Kliner D, et al
    Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26276.
    PubMed     Text format     Abstract available

  33. MAHMUD E, Dominguez A, Bahadorani J
    First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26550.
    PubMed     Text format     Abstract available

  34. EFTYCHIOU C, Barmby DS, Wilson SJ, Ubaid S, et al
    Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience.
    Catheter Cardiovasc Interv. 2016;88:546-553.
    PubMed     Text format     Abstract available

  35. YETGIN T, van Kranenburg M, Ten Cate T, Duncker DJ, et al
    Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
    Catheter Cardiovasc Interv. 2016;88:508-514.
    PubMed     Text format     Abstract available

  36. RITTGER H, Wohrle J, Brachmann J, Hohenforst-Schmidt W, et al
    Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Catheter Cardiovasc Interv. 2016 Feb 19. doi: 10.1002/ccd.26451.
    PubMed     Text format     Abstract available

  37. TEBALDI M, Biscaglia S, Fineschi M, Manari A, et al
    Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study).
    Catheter Cardiovasc Interv. 2016;88:555-562.
    PubMed     Text format     Abstract available

  38. BASAVARAJAIAH S, Naganuma T, Latib A, Sticchi A, et al
    Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Catheter Cardiovasc Interv. 2016;88:522-528.
    PubMed     Text format     Abstract available

  39. TIAN W, Mahmoudi M, Lhermusier T, Kiramijyan S, et al
    The influence of advancing age on implantation of drug-eluting stents.
    Catheter Cardiovasc Interv. 2016;88:516-521.
    PubMed     Text format     Abstract available

  40. LARMORE C, Effron MB, Molife C, DeKoven M, et al
    "Real-World" comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States.
    Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26279.
    PubMed     Text format     Abstract available

  41. THEODOROPOULOS K, Mennuni MG, Dangas GD, Meelu OA, et al
    Resistant in-stent restenosis in the drug eluting stent era.
    Catheter Cardiovasc Interv. 2016;88:777-785.
    PubMed     Text format     Abstract available

  42. DILETTI R, Tchetche D, Barbato E, Latib A, et al
    Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
    Catheter Cardiovasc Interv. 2016;88:397-406.
    PubMed     Text format     Abstract available

  43. TROBS M, Achenbach S, Rother J, Klinghammer L, et al
    Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
    Catheter Cardiovasc Interv. 2016;88:872-880.
    PubMed     Text format     Abstract available

  44. KHAN R, Al-Hawwas M, Hatem R, Azzalini L, et al
    Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Feb 1. doi: 10.1002/ccd.26413.
    PubMed     Text format     Abstract available

  45. KAWAMOTO H, Latib A, Ruparelia N, Boccuzzi GG, et al
    Planned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi-center registry.
    Catheter Cardiovasc Interv. 2016;88:881-889.
    PubMed     Text format     Abstract available

  46. SHAH B, Berger JS, Allen N, Guo Y, et al
    The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.
    Catheter Cardiovasc Interv. 2016 Jan 16. doi: 10.1002/ccd.26353.
    PubMed     Text format     Abstract available

  47. LA MANNA A, Chisari A, Giacchi G, Capodanno D, et al
    Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
    Catheter Cardiovasc Interv. 2016;88:E155-E163.
    PubMed     Text format     Abstract available

  48. JINNOUCHI H, Kuramitsu S, Shinozaki T, Hiromasa T, et al
    Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease.
    Catheter Cardiovasc Interv. 2016;88:E132-E138.
    PubMed     Text format     Abstract available

  49. KHOT UN, Johnson-Wood ML, VanLeeuwen R, Ramsey C, et al
    A hospital-wide system to ensure rapid treatment time across the entire spectrum of emergency percutaneous intervention.
    Catheter Cardiovasc Interv. 2016;88:678-689.
    PubMed     Text format     Abstract available

  50. CHEN SH, Ho KK, Gannon SA, Thyagarajan B, et al
    Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26350.
    PubMed     Text format     Abstract available

  51. DERY JP, Mahaffey KW, Tricoci P, White HD, et al
    Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26335.
    PubMed     Text format     Abstract available

  52. PHILIP F, Stewart S, Southard JA
    Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Catheter Cardiovasc Interv. 2016 Feb 24. doi: 10.1002/ccd.26458.
    PubMed     Text format     Abstract available

  53. AGGARWAL V, Mishkel G, Goswami N
    Percutaneous exclusion of a rapidly enlarging left main coronary artery aneurysm using coils and an Amplatzer septal occluder.
    Catheter Cardiovasc Interv. 2016;88:209-14.
    PubMed     Text format     Abstract available

  54. NAIDU SS, Aronow HD, Box LC, Duffy PL, et al
    SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian Associ
    Catheter Cardiovasc Interv. 2016;88:407-23.
    PubMed     Text format    

  55. GENEREUX P, Bettinger N, Redfors B, Lee AC, et al
    Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Catheter Cardiovasc Interv. 2016;88:369-77.
    PubMed     Text format     Abstract available

  56. IANNACCONE M, Barbero U, D'ascenzo F, Latib A, et al
    Rotational atherectomy in very long lesions: Results for the ROTATE registry.
    Catheter Cardiovasc Interv. 2016;88:E164-E172.
    PubMed     Text format     Abstract available

  57. TURNER ME, Addonizio LJ, Richmond ME, Zuckerman WA, et al
    Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Catheter Cardiovasc Interv. 2016 Apr 16. doi: 10.1002/ccd.26544.
    PubMed     Text format     Abstract available

  58. ADUSUMALLI S, Morris M, Pershad A
    Pseudo-Pericardial Tamponade From Right Ventricular Hematoma After Chronic Total Occlusion Percutaneous Coronary Intervention of the Right Coronary Artery: Successfully Managed Percutaneously With Computerized Tomographic Guided Drainage.
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26510.
    PubMed     Text format     Abstract available

  59. SETO AH, Jordan Safirstein, Anwaruddin S, Dehghani P, et al
    Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
    Catheter Cardiovasc Interv. 2016;87:1224-30.
    PubMed     Text format     Abstract available

  60. MARKOVIC S, Lutzner M, Rottbauer W, Wohrle J, et al
    Zotarolimus compared with everolimus eluting stents-angiographic and clinical results after recanalization of true coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26482.
    PubMed     Text format     Abstract available

  61. IQBAL MB, Nadra IJ, Ding L, Fung A, et al
    Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26479.
    PubMed     Text format     Abstract available

  62. LESCHKE M, Waliszewski M, Pons M, Champin S, et al
    Thin strut bare metal stents in patients with atrial fibrillation: Is there still a need for BMS?
    Catheter Cardiovasc Interv. 2016;88:358-66.
    PubMed     Text format     Abstract available

  63. ABIZAID A, Ribamar Costa J Jr
    The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available

  64. LEE MS, Yang T, Lasala J, Cox D, et al
    Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program.
    Catheter Cardiovasc Interv. 2016 Jan 12. doi: 10.1002/ccd.26395.
    PubMed     Text format     Abstract available

  65. ELGENDY IY, Wen X, Mahmoud A, Bavry AA, et al
    Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: An updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26322.
    PubMed     Text format     Abstract available

  66. DANEK BA, Brilakis ES
    Serenity, courage, and wisdom: The keys to successful coronary calcification treatment.
    Catheter Cardiovasc Interv. 2016;88:897-898.
    PubMed     Text format    

  67. KORNOWSKI R
    Bifurcation stenting with bioresorbable scaffolds: Quo vadis?
    Catheter Cardiovasc Interv. 2016;88:863-864.
    PubMed     Text format    

  68. SAFIAN RD
    Provisional rotablator for calcified lesions: The Russian roulette of PCI.
    Catheter Cardiovasc Interv. 2016;88:889-890.
    PubMed     Text format    

  69. LEESAR MA
    Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
    Catheter Cardiovasc Interv. 2016;88:870-871.
    PubMed     Text format    

  70. BLANKENSHIP JC
    Thrombus aspiration: Suck it up and keep looking for a niche.
    Catheter Cardiovasc Interv. 2016;88:725-726.
    PubMed     Text format    

  71. SETO AH, Kern MJ
    Does the AToMIC trial explode concerns of contrast coagulopathy?
    Catheter Cardiovasc Interv. 2016;88:738-739.
    PubMed     Text format    

  72. TAMBURINO C, Capranzano P, Francaviglia B, Ina Tamburino C, et al
    Update on clinical evidence (Part II): A summary of the main post market studies.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available

  73. FARHAN S, Mehran R
    STEMI with multivessel disease: An ongoing battle for the optimal treatment strategy.
    Catheter Cardiovasc Interv. 2016;88:707-708.
    PubMed     Text format    

  74. BUTMAN SM
    The newly occluded ectatic vessel: Not an ecstatic time.
    Catheter Cardiovasc Interv. 2016;88:753-754.
    PubMed     Text format    

  75. SHARMA R, Henry TD
    Come one, come all...the sooner the better!
    Catheter Cardiovasc Interv. 2016;88:689-690.
    PubMed     Text format    

  76. RIZIK DG, Hermiller JB, Kereiakes DJ
    Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available

  77. CHAMIE D, Garcia-Garcia H, Costa RA, Onuma Y, et al
    Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available

  78. PERKINS LE, Kossuth MB, Fox JC, Rapoza RJ, et al
    Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available

  79. TANAKA A, Jabbour RJ, Latib A, Colombo A, et al
    Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Qual Outcomes

  80. KUMBHANI DJ, Bittl JA
    Much Ado About Nothing? The Relationship of Institutional Percutaneous Coronary Intervention Volume to Mortality.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format    

  81. O'NEILL D, Nicholas O, Gale CP, Ludman P, et al
    Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available


    Circ J

  82. KATSUMATA Y, Sano F, Abe T, Tamura T, et al
    The Effects of Hydrogen Gas Inhalation on Adverse Left Ventricular Remodeling After Percutaneous Coronary Intervention for ST-Elevated Myocardial Infarction- First Pilot Study in Humans.
    Circ J. 2017 Mar 17. doi: 10.1253/circj.CJ-17-0105.
    PubMed     Text format     Abstract available

  83. ISHIHARA M, Nakao K, Ozaki Y, Kimura K, et al
    Long-Term Outcomes of Non-ST-Elevation Myocardial Infarction Without Creatine Kinase Elevation- The J-MINUET Study.
    Circ J. 2017 Mar 17. doi: 10.1253/circj.CJ-17-0033.
    PubMed     Text format     Abstract available


    Circulation


  84. Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2017;135:e789.
    PubMed     Text format    


  85. Correction to: Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Circulation. 2017;135:e788.
    PubMed     Text format    

  86. YEH RW, Kramer DB
    Decision Tools to Improve Personalized Care in Cardiovascular Disease: Moving the Art of Medicine Toward Science.
    Circulation. 2017;135:1097-1100.
    PubMed     Text format    


    Clin Cardiol

  87. GLAZACHEV O, Kopylov P, Susta D, Dudnik E, et al
    Adaptations following an intermittent hypoxia-hyperoxia training in coronary artery disease patients: a controlled study.
    Clin Cardiol. 2017 Mar 21. doi: 10.1002/clc.22670.
    PubMed     Text format     Abstract available


    Clin Chem

  88. CLERICO A, Passino C
    Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction.
    Clin Chem. 2017 Mar 20. pii: clinchem.2016.269522.
    PubMed     Text format    


    Dtsch Med Wochenschr

  89. ODER D, Stork S, Wanner C, Ertl G, et al
    [The Fabry's Disease Cardiomyopathy as Differential Diagnosis of Acute Coronary Syndrome].
    Dtsch Med Wochenschr. 2017;142:442-449.
    PubMed     Text format     Abstract available

  90. DIPPEL FW, Parhofer KG, Muller-Bohn T, Gebhardt S, et al
    [Analysis of Secondary Data to Determine the Prevalence of Cardiovascular High Risk Patients with Hypercholesterolemia and Refractory Course of Treatment].
    Dtsch Med Wochenschr. 2017;142:e34-e41.
    PubMed     Text format     Abstract available


    Eur Heart J

  91. BEBB O, Hall M, Fox KA, Dondo TB, et al
    Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register.
    Eur Heart J. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available

  92. PASEA L, Chung SC, Pujades-Rodriguez M, Moayyeri A, et al
    Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
    Eur Heart J. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cardiol

  93. DAMLUJI AA, Cohen ER, Moscucci M, Myerburg RJ, et al
    Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial.
    Int J Cardiol. 2017 Mar 11. pii: S0167-5273(16)34713.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  94. SCIAHBASI A, Frigoli E, Sarandrea A, Rothenbuhler M, et al
    Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RADMatrix Trial.
    J Am Coll Cardiol. 2017 Mar 15. pii: S0735-1097(17)36042.
    PubMed     Text format     Abstract available


    J Cardiovasc Pharmacol

  95. SCHUMACHER SM, Koch WJ
    Non-canonical roles of GRKs in cardiovascular signaling.
    J Cardiovasc Pharmacol. 2017 Mar 17. doi: 10.1097/FJC.0000000000000483.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  96. YU E, Ruiz-Canela M, Hu FB, Clish CB, et al
    Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
    J Clin Endocrinol Metab. 2017 Mar 2. doi: 10.1210/jc.2016-3569.
    PubMed     Text format     Abstract available

  97. HANSEN L, Netterstrom MK, Johansen NB, Ronn PF, et al
    Metabolically healthy obesity and ischemic heart disease: a 10-year follow-up of the Inter99 study.
    J Clin Endocrinol Metab. 2017 Mar 7. doi: 10.1210/jc.2016-3346.
    PubMed     Text format     Abstract available

  98. CHIN K, Zhao D, Tibuakuu M, Martin SS, et al
    Physical activity, Vitamin D, and Incident Atherosclerotic Cardiovascular Disease in Whites and Blacks: the ARIC Study.
    J Clin Endocrinol Metab. 2017 Feb 17. doi: 10.1210/jc.2016-3743.
    PubMed     Text format     Abstract available


    JAMA

  99. AGORITSAS T, Merglen A, Shah ND, O'Donnell M, et al
    Adjusted Analyses in Studies Addressing Therapy and Harm: Users' Guides to the Medical Literature.
    JAMA. 2017;317:748-759.
    PubMed     Text format     Abstract available

  100. BILECEN S, de Groot JA, Kalkman CJ, Spanjersberg AJ, et al
    Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.
    JAMA. 2017;317:738-747.
    PubMed     Text format     Abstract available


    Lancet

  101. KAPLAN H, Thompson RC, Trumble BC, Wann LS, et al
    Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study.
    Lancet. 2017 Mar 16. pii: S0140-6736(17)30752.
    PubMed     Text format     Abstract available

  102. OHMAN EM, Roe MT, Steg PG, James SK, et al
    Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Lancet. 2017 Mar 17. pii: S0140-6736(17)30751.
    PubMed     Text format     Abstract available

  103. GURBEL PA, Tantry US
    GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes.
    Lancet. 2017 Mar 17. pii: S0140-6736(17)30760.
    PubMed     Text format    


    N Engl J Med

  104. ELLISON DH
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194.
    PubMed     Text format    


  105. Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194-5.
    PubMed     Text format    

  106. RAPPAPORT SM, Neophytou AM
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1193.
    PubMed     Text format    

  107. SMITS PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, et al
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMoa1701067.
    PubMed     Text format     Abstract available

  108. KOBER L
    Complete Revascularization in ST-Elevation Myocardial Infarction?
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMe1702825.
    PubMed     Text format    

  109. KULLO IJ, Fan X, Ding K
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1192-3.
    PubMed     Text format    


    PLoS One

  110. CHA MJ, Kim HS, Kim SH, Park JH, et al
    Prognostic power of global 2D strain according to left ventricular ejection fraction in patients with ST elevation myocardial infarction.
    PLoS One. 2017;12:e0174160.
    PubMed     Text format     Abstract available

  111. NEUMANN JT, Sorensen NA, Ojeda F, Renne T, et al
    Early diagnosis of acute myocardial infarction using high-sensitivity troponin I.
    PLoS One. 2017;12:e0174288.
    PubMed     Text format     Abstract available

  112. LIU N, Wang BJ, Broughton KM, Alvarez R, et al
    PIM1-minicircle as a therapeutic treatment for myocardial infarction.
    PLoS One. 2017;12:e0173963.
    PubMed     Text format     Abstract available

  113. LEI WY, Wang JH, Wen SH, Yi CH, et al
    Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population-based study.
    PLoS One. 2017;12:e0173899.
    PubMed     Text format     Abstract available


    Thromb Haemost

  114. CAMPO G, Vieceli Dalla Sega F, Pavasini R, Aquila G, et al
    Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.
    Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0973.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: